Pharmaceuticals.jpg

Pharmaceuticals

Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture. Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

19387-91-8

Tinidazole

19387-91-8
57-85-2

Testosterone Propionate

57-85-2
158062-71-6

4-(Trifluoromethyl)nicotinamide

158062-71-6
504-17-6

2-Thiobarbituric Acid

504-17-6
871700-17-3

Trametinib

871700-17-3
124-94-7

Triamcinolone

124-94-7
526-55-6

Tryptophol

526-55-6
23031-32-5

Terbutaline Hemisulfate Salt

23031-32-5
56776-01-3

Tulobuterol HCl

56776-01-3
10161-33-8

Trenbolone

10161-33-8
479073-90-0

Propoxyphenyl-thiohydroxyhomosildenafil

479073-90-0
69004-03-1

Toltrazuril

69004-03-1
53939-83-6

6-Ethyl-2-thiouracil

53939-83-6
6336-50-1

6-Benzyl-2-thiouracil

6336-50-1
206184-49-8

Tenofovir H2O

206184-49-8
70028-95-4

Ternidazole HCl

70028-95-4
55560-96-8

Tixocortol 21-Pivalate

55560-96-8
39133-31-8

Trimebutine

39133-31-8
106463-17-6

Tamsulosin Hydrochloride

106463-17-6
147127-20-6

Tenofovir

147127-20-6